Poland, Dec. 8 -- Poland based Takeda Pharma Sp. z o. o. has secured contract from Beskidzkie Centrum Onkologii- Szpital Miejski im. Jana Pawla II w Bielsku-Bialej. for Pharmaceutical products - Delivery of cytostatic drugs, including cytostatic drugs necessary to provide chemotherapy services and drug programs for the needs of the Beskid Oncology Center - John Paul II Municipal Hospital in Bielsko-Biala. The value of the contract is worth 40674320 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....